Nektar Therapeutics (NKTR)
0.9282
-0.01
(-1.36%)
USD |
NASDAQ |
Dec 20, 16:00
0.9213
-0.01
(-0.74%)
After-Hours: 20:00
Nektar Therapeutics Gross Profit Margin (Quarterly): 81.62% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -154.2% |
| Return on Assets | -44.58% |
| Return on Invested Capital | -154.2% |
| Profit Margin (Quarterly) | -153.6% |
| Operating Margin (Quarterly) | -142.2% |
| Return on Net Operating Assets | -318.6% |